Aerie Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2013 Financial Results And Provides Business And Product Development Update
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on the Company’s business highlights.
Help employers find you! Check out all the jobs and post your resume.